ERBB2 and breast carcinoma: In many clinical studies, luminal B breast cancer is considered as a single type when analyzing clinical relevance and outcomes.[4,5,19–21] However, because the treatment strategies are different for HER2− and HER2 + luminal B breast cancers, they should be analyzed as 2 distinct types.